Global framework for biosimilars "is now crucial"

Article Date: 25/04/2012 06:00
Global framework for biosimilars "is now crucial"

Vacancy Search

Quick job search

Advanced Search

Latest News

Patient empowerment key to trial recruitment, report finds

Patient empowerment key to trial recruitment, report finds

Shire wins pharma company of the year at PT awards

Shire wins pharma company of the year at PT awards

Impressive survival data for Clovis' rociletinib

Impressive survival data for Clovis' rociletinib

European cardiologists warn over AF diagnosis delays

European cardiologists warn over AF diagnosis delays

UK group MBS signs £176 mill RA pact with Janssen

UK group MBS signs £176 mill RA pact with Janssen

BLOG: Is prescribing health apps to patients set to be the new practice?

BLOG: Is prescribing health apps to patients set to be the new practice?

BI's Vargatef bags EU approval for lung cancer

BI's Vargatef bags EU approval for lung cancer

NICE backs Soliris at £340K per patient per year

NICE backs Soliris at £340K per patient per year

Upcoming events: Migraine data for Amgen and CHMP verdict for Newron

Welcome to your weekly digest of approaching regulatory and clinical readouts. By year end phase IIb results are expected from Amgen’s AMG 334 in episodic migraine. With the likes of Lilly...

Promising start for GSK and NIH Ebola vaccine

Promising start for GSK and NIH Ebola vaccine
more news